Article Figures & Data
Figures
- Figure 1.
Multimorbidity prevalence by age, stratified by sex. Prevalence rates were estimated using hierarchical logistic regression models (see Methods for details).
Tables
- Table 1. Prevalence of Chronic Conditions Among 667,379 Active Patients and 148 Practices as of October 1, 2011
Chronic Condition ICD-9-CM Codes* Prevalence Among All Patients, % (n) Prevalence Among Practices, median % (10th, 90th percentile) Hypertension 362.11, 401, 402, 403, 404, 405, 437.2, 997.91 33.51 (223,653) 35.77 (22.62, 53.63) Hyperlipidemia 272.0–272.1, 272.3, 272.4, 277.7 32.97 (220,053) 34.74 (20.40, 55.70) Depression 290.13, 290.21, 296.2, 296.3, 298.0, 300.4, 311 18.67 (124,596) 20.15 (9.47, 30.37) Gastroesophageal reflux 530.11, 530.81, 530.85 14.93 (99,658) 15.63 (6.49, 27.39) Diabetes mellitus 250, 357.2, 362.0, 366.41 11.93 (79,641) 12.80 (6.72, 20.31) Obesity 278.09, 278.01, 278.03, 278.8, V85.3, V85.4 11.90 (79,407) 9.66(3.31, 25.92) Osteoarthritis 715, 721 (excluding 721.7, 721.8) 9.93 (66,255) 8.95 (2.47,21.20) Asthma 493 (excluding 493.81) 8.73 (58,900) 7.99 (4.84, 14.27) Osteoporosis and osteopenia 733.0, 733.90 (with text indicating osteopenia) 6.55 (43,700) 5.51 (1.96, 12.74) Migraine 346 5.66 (37,756) 5.42 (2.70, 9.75) Coronary disease 410, 411, 412, 413, 414, 429.7, P36.0, P36.1, P36.3, V45.81, V45.82 4.92 (32,867) 4.76 (1.50, 10.89) Atherosclerosis 290.4, 433, 434, 435, 436 437.0, 437.8, 437.9, 438, 440, 441, 442, 443, 444, 445, P38.12, P38.44, P39.22, P39.24, P39.25, P39.28, P39.29, V12.54 4.74 (31,638) 4.11 (1.44, 11.16) Chronic obstructive pulmonary disease 491, 492, 496 4.35 (29,005) 4.02 (1.37, 9.29) Chronic kidney disease 250.4, 285.21, 403, 404, 581, 582, 583, 585, 586, 587, 588, 996.73, V42.0, V45.1 3.37 (22,496) 2.55 (0.87, 8.73) Cerebrovascular disease 290.4, 430, 431, 432, 433, 434, 435, 436, 437, 438, 439, P38.12, P38.44, V12.54 2.88 (19,227) 2.44 (0.88, 6.78) Atrial fibrillation 427.31 2.17 (14,487) 2.07 (0.69, 4.49) Heart failure 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428 1.68 (11,241) 1.67 (0.50, 3.76) Alcohol use disorders 291, 303, 305.0, 357.5, 425.5, 535.3, 571.0–571.3, 790.3, 980.0, 980.9, P94.62 1.29 (8594) 1.30 (0.43, 3.01) Dementia 046.1, 290, 291.2, 292.82, 294.1, 330.1, 331.0, 331.1, 331.2, 331.82 1.10 (7361) 0.93 (0.27, 2.47) Peptic ulcer 531, 532, 533, 534, V12.71 1.09 (7242) 0.94 (0.19, 2.26) Chronic liver disease 070.22, 070.23, 070.32, 070.33, 070.44, 070.54, 155, 197.7, 571.2, 571.4, 571.5, 571.6, 571.8, 571.9, 572.2, 572.4, 572.8, 996.82, P50.4, P50.59, V10.07, V42.7 1.04 (6951) 0.82 (0.27, 2.55) Epilepsy 345 1.03 (6893) 1.01 (0.36, 1.74) Rheumatoid arthritis 714 0.95 (6357) 0.91 (0.37, 1.76) Parkinson's disease or syndrome 332.0 0.28 (1886) 0.23 (0.00, 0.67) ↵* The International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) codes were either included in the database diagnoses lists or derived by the PPRNet algorithms (see text). P set before a number indicates a procedure code. Codes used but not listed include G-codes used for quality reporting and procedure codes used for procedures unique to a diagnosis (eg, diabetic eye examination, gastric bypass for obesity).
- Table 2. Number of Chronic Conditions Among 667,379 Active Patients and 148 Practices as of October 1, 2011
Chronic Conditions (n) Patients in All Practices, % (n) Prevalence Among Practices, Median (10th, 90th Percentile) 0 34.65 (231,235) 30.11 (14.02, 47.66) 1 20.10 (134,136) 19.76 (12.88, 24.92) 2 14.89 (99,367) 15.47 (12.01, 18.59) 3 11.18 (74,586) 11.86 (7.61, 15.48) 4 7.67 (51,163) 8.44 (4.00, 12.76) 5 4.89 (32,652) 5.36 (1.93, 9.90) 6 2.97 (19,821) 3.07 (0.94, 6.54) 7 to 23 3.66 (24,419) 0.31 (0.04, 1.05) - Table 3. Prevalence of Multimorbidity by Age and Definition Among All 667,379 Active Patients and 148 Practices as of October 1, 2011
Age (Years) ≥2 Chronic Conditions ≥3 Chronic Conditions Chronic Conditions, Median (IQR) Patients in All Practices* Prevalence Among Practices† Patients in All Practices* Prevalence Among Practices† 18–34 13.85 (22,025) 14.21 (6.58, 28.98) 4.97 (7911) 4.93 (1.86, 13.60) 0 (0–1) 35–44 29.83 (31,683) 32.50 (16.47, 55.43) 15.10 (16,032) 15.73 (6.58, 34.54) 1 (0–2) 45–54 44.82 (58,022) 47.48 (26.69, 69.97) 26.88 (34,794) 27.90 (11.76, 50.78) 1 (0–3) 55–64 61.00 (76,684) 66.01 (41.19, 81.93) 71.92 (52,594) 44.62 (24.20, 65.33) 2 (1–4) 65–74 74.30 (59,902) 78.74 (54.12, 91.57) 57.35 (46,231) 60.63 (35.55, 79.34) 3 (1–4) 75–84 80.99 (37,668) 87.26 (60.32, 96.50) 67.51 (31,402) 73.79 (42.80, 88.39) 4 (2–5) ≥85 80.82 (16,024) 87.30 (61.55, 98.34) 68.99 (13,677) 75.66 (44.09, 92.69) 4 (2–6)
In this issue
The Prevalence of Chronic Diseases and Multimorbidity in Primary Care Practice: A PPRNet Report
Jump to section
Related Articles
Cited By...
- CM-SHARE: Development, Integration, and Adoption of an Electronic Health Record-Linked Digital Health Solution to Support Care for Diabetes in Primary Care
- Prevalence, characteristics, and patterns of patients with multimorbidity in primary care: a retrospective cohort analysis in Canada
- Expanding incentives for coordinated, patient-centered care: Implications for neurologists
- Effect of socio-demographic factors on the association between multimorbidity and healthcare costs: a population-based, retrospective cohort study
- Functional disability and social participation restriction associated with chronic conditions in middle-aged and older adults
- Prevalence And Spending Associated With Patients Who Have A Behavioral Health Disorder And Other Conditions
- Risk-adjusted survival for adults following in-hospital cardiac arrest by day of week and time of day: observational cohort study
- Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease
- Prevalence of multimorbidity in the adult population attending primary care in Portugal: a cross-sectional study
- Patient-Centered Research Happens in Practice-based Research Networks